Observational Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. May 27, 2023; 15(5): 931-939
Published online May 27, 2023. doi: 10.4240/wjgs.v15.i5.931
Figure 1
Figure 1 Receiver operating characteristic curve of matrix metalloproteinases 2, 7, 9 and carcinoembryonic antigen alone for distinguishing healthy control group from colorectal cancer group. A: Matrix metalloproteinase (MMP) 2; B: MMP7; C: MMP9; D: Carcinoembryonic antigen.
Figure 2
Figure 2 Receiver operating characteristic curve of matrix metalloproteinases 2, 7, 9 and carcinoembryonic antigen joint for distinguishing healthy control group from colorectal cancer group. A: Healthy control group vs colorectal cancer group; B: Healthy control group vs early stage of colorectal cancer group; C: Healthy control group vs advanced stage of colorectal cancer group.
Figure 3
Figure 3 Receiver operating characteristic curve of matrix metalloproteinases 7, 9 and carcinoembryonic antigen alone for distinguishing colorectal polyp group from colorectal cancer group. A: Matrix metalloproteinase (MMP) 7; B: MMP9; C: Carcinoembryonic antigen.
Figure 4
Figure 4 Receiver operating characteristic curve of matrix metalloproteinases 2, 7, 9 and carcinoembryonic antigen joint for distinguishing colorectal polyp from colorectal cancer group. A: Colorectal polyp group vs colorectal cancer group; B: Colorectal polyp group vs early stage of colorectal cancer group; C: Colorectal polyp group vs advanced stage of colorectal cancer group.